A Collaboration with the University of Pittsburgh

Texas appeals court overturns jury award against Merck in Vioxx case

[JURIST] A Texas appeals court Wednesday overturned [opinion text] a jury verdict [JURIST report] that found pharmaceutical giant Merck [corporate website] liable for the death of a 71-year-old man who died from a heart attack within a month of taking Merck's painkiller Vioxx [Merck Vioxx Information Center website; JURIST news archive]. The jury had ordered Merck to pay $32 million in damages to the family of Leonel Garza - $7 million in non-economic compensatory damages and $25 million in punitive damages - but a state cap later reduced that amount to $7.75 million. The Texas Fourth Court of Appeals [official website] found that Garza's family had failed to show that Garza's heart problems were tied to his use of Vioxx.

Merck has been involved in a stream of Vioxx-related litigation during the last few years, including state and federal lawsuits in Louisiana, New Jersey, and California [JURIST reports]. In September 2007, the New Jersey Supreme Court dismissed [JURIST report] a class action lawsuit filed against Merck, reversing a lower court's decision to grant nationwide class certification in the case. In November 2007, Merck said that it had agreed to pay $4.85 billion to settle all pending lawsuits [press release; JURIST report] regarding its marketing and distribution of Vioxx. AP has more.

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.